Provided by Tiger Trade Technology Pte. Ltd.

Merck

150.66
-1.8900-1.24%
Post-market: 150.670.0096+0.01%18:24 EDT
Volume:15.01M
Turnover:2.26B
Market Cap:371.70B
PE:118.36
High:151.52
Open:150.72
Low:149.14
Close:152.55
52wk High:154.49
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:0.90
T/O Rate:0.61%
Dividend:3.32
Dividend Rate:2.20%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.86
PE(LYR):20.70

Loading ...

Beyond AI: Where Value Funds See Bargains Now -- Barron's

Dow Jones
·
Jun 13

Merck & Co. Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 13

FDA approves Keytruda-Welireg combination for adjuvant treatment of ccRCC

TIPRANKS
·
Jun 13

Sector Update: Healthcare

MT Newswires Live
·
Jun 13

Merck's Belzutifan Combination Approved by FDA for Adjuvant Treatment of Renal Cell Carcinoma

MT Newswires Live
·
Jun 13

FDA Approves Belzutifan With Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma

THOMSON REUTERS
·
Jun 13

FDA approves Merck’s belzutifan with Keytruda for renal cell carcinoma

TIPRANKS
·
Jun 13

8 Great stocks that have nothing to do with AI: Jon Erlichman

Bloomberg
·
Jun 12

Movement Alert|Merck Rises 3.03% in Regular Trading, Multiple Pipeline Catalysts Including HPV Vaccine Expansion and HIV Trial Success

Market Focus
·
Jun 12

Merck Animal Health to acquire Targan

TIPRANKS
·
Jun 11

Corrected-Merck Co - Merck Animal Health (Not 'Animal Health') to Buy Targan for Undisclosed Price

THOMSON REUTERS
·
Jun 11

Merck Animal Health agrees to buy poultry biodevice maker TARGAN

Reuters
·
Jun 11

Merck Animal Health to Acquire Targan

THOMSON REUTERS
·
Jun 11

Merck & Co - Acquisition Expected to Close in Q3 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Jun 11

Beyond AI: Where Value Funds Are Finding Bargains Now -- Barrons.com

Dow Jones
·
Jun 11

MRK Holdings FY Net Y930.00M Vs Net Y254.00M

Dow Jones
·
Jun 10

FOCUS-Cancer vaccines based on mRNA advance, despite US cuts

Reuters
·
Jun 10

Merck Exec Says "We Are Interested in Looking at the Broader Obesity Space, but Less About Obesity Than Its Comorbidities"

THOMSON REUTERS
·
Jun 09

Merck CEO Says Co Will Focus on $1 Billion to $15 Billion "Sweet Spot" for M&a - Goldman Sachs Healthcare Conference

THOMSON REUTERS
·
Jun 09

Merck CEO Says "We Need a Steady, Stable, Predictable FDA"

THOMSON REUTERS
·
Jun 09